The true risk of blood transfusion after nephrectomy for renal masses: A population-based study

BJU International

Volumn 111, Issue 8, 2013, Pages 1294-1300

  Vricella, Gino J ^a   Finelli, Antonio ^b   Alibhai, Shabbir M H ^c   Ponsky, Lee E ^a   Abouassaly, Robert ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b PRINCESS MARGARET HOSPITAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

blood transfusion; nephrectomy; renal cell carcinoma

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BLOOD TRANSFUSION; CHARLSON COMORBIDITY INDEX; CLINICAL PRACTICE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; EXPLANATORY VARIABLE; FEMALE; HUMAN; KIDNEY TUMOR; LAPAROSCOPIC SURGERY; MAJOR CLINICAL STUDY; MALE; NEPHRECTOMY; OBSERVATIONAL STUDY; PARTIAL NEPHRECTOMY; POPULATION RESEARCH; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEX DIFFERENCE; SURGICAL TECHNIQUE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOOD TRANSFUSION; CANADA; CARCINOMA, RENAL CELL; COMORBIDITY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEPHRECTOMY; POSTOPERATIVE HEMORRHAGE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; YOUNG ADULT;

EID: 84878327446     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2012.11721.x     Document Type: Article

References (29)

1. Ferraris VA, Brown JR, Despotis GJ, et al. 2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines. Ann Thorac Surg 2011; 91: 944-982
2. Klein HG, Spahn DR, Carson JL,. Red blood cell transfusion in clinical practice. Lancet 2007; 370: 415-426 (Pubitemid 47176657)
3. Sun M, Bianchi M, Trinh QD, et al. Hospital volume is a determinant of postoperative complications, blood transfusion and length of stay after radical or partial nephrectomy. J Urol 2012; 187: 405-410
4. Sun M, Abdollah F, Shariat SF, et al. Propensity-score matched comparison of complications, blood transfusions, length of stay and in-hospital mortality between open and laparoscopic partial nephrectomy: a national series. Eur J Surg Oncol 2012; 38: 80-87
5. Discharge Abstract Database. Canadian Institute for Health Information. Available at: http://www.cihi.ca/cihi-ext-portal/internet/en/document/ types+of+care/hospital+care/acute+care/services-dad. Accessed July 1, 2011
6. Statistics Canada. 2006 Census Data. Available at: http://statcan.gc.ca/. Accessed December 8, 2011
7. Charlson ME, Pompei P, Ales KL, MacKenzie CR,. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-383 (Pubitemid 17055592)
8. Deyo RA, Cherkin DC, Ciol MA,. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992; 45: 613-619
9. Newschaffer CJ, Bush TL, Penberthy LE, Bellantoni M, Helzlsour K, Diener-West M,. Does comorbid disease interact with cancer? An epidemiologic analysis of mortality in a cohort of elderly breast cancer patients. J Gerontol A Biol Sci Med Sci 1998; 53: M372-378 (Pubitemid 29010744)
10. Blundell J,. Some account of a case of obstinate vomiting in which an attempt was made to prolong life by the injection of blood into the veins. Med Chir Trans 1818; 10: 296-311
11. Hebert PC, Wells G, Blajchman MA, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 1999; 340: 409-417 (Pubitemid 29084771)
12. Corwin HL, Gettinger A, Pearl RG, et al. The CRIT study: anemia and blood transfusion in the critically ill-current clinical practice in the United States. Crit Care Med 2004; 32: 39-52 (Pubitemid 38125561)
13. Vincent JL, Baron JF, Reinhart K, et al. Anemia and blood transfusion in critically ill patients. JAMA 2002; 288: 1499-1507
14. Jeong W, Rha KH, Kim HH, et al. Comparison of laparoscopic radical nephrectomy and open radical nephrectomy for pathologic stage T1 and T2 renal cell carcinoma with clear cell histologic features: a multi-institutional study. Urology 2011; 77: 819-824
15. Tan HJ, Wolf JS Jr, Ye Z, Wei JT, Miller DC,. Population-level comparative effectiveness of laparoscopic versus open radical nephrectomy for patients with kidney cancer. Cancer 2011; 117: 4184-4193
16. Gill IS, Kamoi K, Aron M, Desai MM,. 800 laparoscopic partial nephrectomies: a single surgeon series. J Urol 2010; 183: 34-41
17. Gill IS, Kavoussi LR, Lane BR, et al. Comparison of 1,800 laparoscopic and open partial nephrectomies for single renal tumors. J Urol 2007; 178: 41-46 (Pubitemid 46898481)
18. Hollenbeck BK, Dunn RL, Miller DC, Daignault S, Taub DA, Wei JT,. Volume-based referral for cancer surgery: informing the debate. J Clin Oncol 2007; 25: 91-96 (Pubitemid 350010639)
19. Mitchell RE, Lee BT, Cookson MS, et al. Radical nephrectomy surgical outcomes in the University Health System Consortium Data Base: impact of hospital case volume, hospital size, and geographic location on 40,000 patients. Cancer 2009; 115: 2447-2452
20. Birkmeyer NJ, Goodney PP, Stukel TA, Hillner BE, Birkmeyer JD,. Do cancer centers designated by the National Cancer Institute have better surgical outcomes? Cancer 2005; 103: 435-441
21. Kneuertz PJ, Patel SH, Chu CK, et al. Effects of perioperative red blood cell transfusion on disease recurrence and survival after pancreaticoduodenectomy for ductal adenocarcinoma. Ann Surg Oncol 2011; 18: 1327-1334
22. Chau JK, Harris JR, Seikaly HR,. Transfusion as a predictor of recurrence and survival in head and neck cancer surgery patients. J Otolaryngol Head Neck Surg 2010; 39: 516-522
23. Ling FC, Hoelscher AH, Vallbohmer D, et al. Leukocyte depletion in allogeneic blood transfusion does not change the negative influence on survival following transthoracic resection for esophageal cancer. J Gastrointest Surg 2009; 13: 581-586
24. Busch OR, Hop WC, Hoynck van Papendrecht MA, Marquet RL, Jeekel J,. Blood transfusions and prognosis in colorectal cancer. N Engl J Med 1993; 328: 1372-1376 (Pubitemid 23131389)
25. Heis MM, Mempel W, Delanoff C, et al. Blood transfusion-modulated tumor recurrence: first results of a randomized study of autologous versus allogeneic blood transfusion in colorectal cancer surgery. J Clin Oncol 1994; 12: 1859-1867 (Pubitemid 24349388)
26. Blajchman MA,. Transfusion-associated immunomodulation and universal white cell reduction: are we putting the cart before the horse? Transfusion 1999; 39: 665-670 (Pubitemid 29328476)
27. Brunson ME, Alexander JW,. Mechanisms of transfusion-induced immunosuppression. Transfusion 1990; 30: 651-658 (Pubitemid 20317440)
28. Ford BS, Sharma S, Rezaishiraz H, Huben RS, Mohler JL,. Effect of perioperative blood transfusion on prostate cancer recurrence. Urol Oncol 2008; 26: 364-367 (Pubitemid 351885373)
29. Paul R, Schmid R, Busch R, et al. Influence of blood transfusions during radical retropubic prostatectomy on disease outcome. Urology 2006; 67: 137-141 (Pubitemid 43069272)